SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 73 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $566,000 | +76.9% | 75,730 | +157.1% | 0.00% | +50.0% |
| Q4 2020 | $320,000 | +199.1% | 29,457 | +143.3% | 0.00% | +100.0% |
| Q3 2020 | $107,000 | +57.4% | 12,105 | +5.2% | 0.00% | -50.0% |
| Q1 2020 | $68,000 | -78.1% | 11,512 | -74.4% | 0.00% | 0.0% |
| Q4 2019 | $311,000 | – | 44,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |